What is the current target price for the Qualigen Therapeutics Inc share?

The average Qualigen Therapeutics Inc target price is $5.00. This is 2,673.16% higher than the current share price. 1 Analyst has issued a Qualigen Therapeutics Inc price target 2025.

How high will the Qualigen Therapeutics Inc share rise?

No reliable answer can be given as to how high the Qualigen Therapeutics Inc share will rise. The performance of shares, including the Qualigen Therapeutics Inc share, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Qualigen Therapeutics Inc share today?

The performance of Qualigen Therapeutics Inc shares on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Qualigen Therapeutics Inc share fall?

The decline in Qualigen Therapeutics Inc shares may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's share price could be in a certain period of time, usually 12 months.

Qualigen Therapeutics Inc Forecast, price target & analysts

$0.18

6.58% yesterday

Nasdaq, Jun 25, 10:16 pm CET

ISIN

US74754R1032

Symbol

QLGN

Reports

Quarter | Year

Index

NASDAQ Composite

Sector

Gesundheit

Industry

Pharma

Overview Dividends Analysts Charts News Strategies

Qualigen Therapeutics Inc Target price 2024 - Analyst rating & recommendation

Qualigen Therapeutics Inc Classifications & Recommendation:

Buy

100%

Qualigen Therapeutics Inc Target price

Target price	$5.00
Course	$0.18
Price potential	2,673.16% register free of charge
Number of estimates	1

	1 Analyst has issued a Qualigen Therapeutics Inc price target 2025. The average Qualigen Therapeutics Inc target price is $5.00. This is 2,673.16% register free of charge higher than the current share price.
	A rating was issued by 1 analysts: 1 Analysts recommend Qualigen Therapeutics Inc to buy, 0 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst estimates: Analysts believe that the Qualigen Therapeutics Inc share has an average upside potential 2025 of 2,673.16% register free of charge . Most analysts recommend the Qualigen Therapeutics Inc share at Purchase.

Earnings per share, P/E ratio and EV/sales forecast 2024, 2025 & 2026

Create a premium account to unlock analyst estimates. Learn more

Annually

	Dec '23	2024 Forecast
Earnings per share $	-2.53	-1.00
	47.84%	60.47%
P/E ratio		negative

1 Analysts have issued a Qualigen Therapeutics Inc forecast for earnings per share. The average Qualigen Therapeutics Inc <a href=/blog/eps>EPS is

unlock

. This is

unlock

than earnings per share in the financial year 2023. The highest <a href=/blog/eps>EPS forecast is

unlock

, the lowest is

unlock

This results in the following potential growth figures and future valuations:

2023	$-2.53	47.84%
2024	$-1.00 60.47% unlock
2025	$-0.71 29.00% unlock

Current	-0.07	65.00%
2024	-0.41 485.71% unlock
2025	-0.58 41.46% unlock

Qualigen Therapeutics Inc...

Discover more stocks with a high price target

Valneva 174.32%

CureVac N.V. 142.91%

Plug Power Inc. 104.26%

ThyssenKrupp 87.27%

Evotec 85.02%

Bavarian Nordic 72.00%

Alibaba Group Holding Ltd 41.08%

Register for free

StocksGuide is the tool for easily finding, analyzing and monitoring shares. Learn from successful investors and make well-founded investment decisions. We make you a self-determined investor.

Start now